Category :   International experience

APPLICATION OF ERBISOL^® ULTRAPHARM FOR THE TREATMENT OF PATIENTS WITH PANCREATIC CANCER

Authors:Zhylchuk A.V. Коrnilina Е.М. Kudryavets Yu.I. Maksymiak G.I. ... №21 1 2019 135

NOVEL DIFFERENTIATION ANTIGENS OF NORMAL AND NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELLS (ACCORDING TO HLDA9 AND HLDA10 INTERNATIONAL WORKSHOPS)

Authors:Philchenkov A.A. Gluzman D.F. Ivanivska T.S. №21 2 2019 50

A MULTICENTRE STUDY OF CAPECITABINE, OXALIPLATIN PLUS BEVACIZUMAB AS PERIOPERATIVE TREATMENT OF PATIENTS WITH POOR-RISK COLORECTAL LIVERONLY METASTASES NOT SELECTED FOR UPFRONT RESECTION

№13 1 2011 1

ADMINISTRATION OF XELOD IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER

Authors:Dobrova N.V. №13 1 2011 9

BEVACIZUMAB IN 1ST LINE OF COMPLEX TREATMENT IN PATIENTS WITH OVARIAN CANCER (PHASE III CLINICAL TRIAL)

№14 5 2012 1

CAPECITABINE AND FLUOROURACIL IN THE TREATMENT OF COLORECTAL AND GASTRIC CANCER: COMPARATIVE ANALYSIS

Authors:Fedianin M.Y. Triakin A.A. №14 5 2012 2

EFFICIENCY OF COMBINATION OF BEVACIZUMAB AND CHEMOTHERAPY WITH GEMCITABINE AND CARBOPLATIN IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCER

№15 1 2013 No views

IIMPROVED SURVIVAL WITH VEMURAFENIB IN MELANOMA WITH BRAF V600E MUTATION

№15 1 2013 4

DIAGNOSIS AND DRUG THERAPY IN PRIMARY AND METASTATIC BREAST CANCER: RECOMMENDATIONS ESMO 2012, RUSSCO 2012, NCCN 2013

№15 2 2013 1

THE EFFICACY OF COMBINATION BEVACIZUMAB WITH CHEMOTHERAPY 2nd-LINE OF PATIENTS WITH ADVANCED COLORECTAL CANCER

№15 2 2013 5

12»